BioMarin Pharmaceutical Inc. (BMRN) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

BioMarin Pharmaceutical Inc. (BMRN) - Medical Equipment - Deals and Alliances Profile

BioMarin Pharmaceutical Inc. (BMRN) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
BioMarin Pharmaceutical Inc. (BMRN) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
40 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

BioMarin Pharmaceutical Inc. (BioMarin) is a biopharmaceutical company which develops and commercializes innovative pharmaceuticals that treat serious diseases and medical conditions. The company offers products for the treatment of various diseases such as Kyndrisa (drisapersen), Duchenne muscular dystrophy (DMD), phenylketonuria (PKU), achondroplasia, late infantile neuronal ceroid lipofuscinosis (CLN2) and hemophilia A. Its product portfolio consists of products and multiple clinical and preclinical product candidates. The company operates through its manufacturing facilities in Novato, California and has its presence in US, Europe, Latin America, the Middle East, and Asia-Pacific.

BioMarin Pharmaceutical Inc. (BMRN) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company&l

  
Source:
Document ID
GDME27812D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
BioMarin Pharmaceutical Inc., Medical Equipment, Deals By Year, 2010 to YTD 201642
BioMarin Pharmaceutical Inc., Medical Equipment Deals By Type, 2010 to YTD 201661
BioMarin Pharmaceutical Inc., Medical Equipment, Deals By Region, 2010 to YTD 201671
BioMarin Pharmaceutical Inc., Medical Equipment, Deals By Market, 2010 to YTD 201681
BioMarin Pharmaceutical Inc., Medical Equipment, Deals Summary, 2010 to YTD 201691
BioMarin Pharmaceutical Inc., Medical Equipment, Deal Details1010
  Partnerships101
    Zacharon Enters Into Licensing Agreement With Shire For Sensi Pro Assay101
    Zacharon Pharma Enters Into Licensing Agreement With Arup Labs For Sensi-Pro Assay111
  Equity Offering121
    BioMarin Pharma Prices Public Offering of Shares for USD720 Million122
    BioMarin Pharma Completes Public Offering Of Shares For US$119.3 Million141
  Debt Offering151
    BioMarin Pharma Completes Public Offering Of Notes Due 2018 For US$375 Million152
    BioMarin Pharma Completes Public Offering Of Notes Due 2020 For US$375 Million172
  Acquisition191
    Roche Rumored To Acquire BioMarin Pharma For US$13.5 Billion191
BioMarin Pharmaceutical Inc. - Key Competitors201
Key Employees212
Locations And Subsidiaries232
  Head Office231
  Other Locations &Subsidiaries232
Recent Developments251
Strategy And Business Planning251
Sep 30, 2015: Parent Project Muscular Dystrophy Launches Next Phase of Genetic Testing Program, Decode Duchenne in collaboration with BioMarin Pharmaceutical PTC Therapeutics, and Sarepta Therapeutics251
Financial Announcements261
Apr 28, 2016: BioMarin Announces First Quarter 2016 Financial Results262
Feb 25, 2016: BioMarin Announces Fourth Quarter and Full Year 2015 Financial Results282
Aug 03, 2015: BioMarin Announces Second Quarter 2015 Financial Results and Company Update302
Apr 30, 2015: BioMarin Announces First Quarter 2015 Financial Results and Company Update322
Feb 25, 2015: BioMarin Announces Fourth Quarter and Full Year 2014 Financial Results342
Corporate Communications361
Jul 18, 2016: BioMarin Appoints Two BioPharmaceutical Veterans to Board of Directors, Willard Dere, M.D. and Kathryn E. Falberg362
Jan 04, 2016: BioMarin Announces Addition of David Pyott, Former Allergan Chairman and CEO, to Company's Board of Directors381
Jan 07, 2015: BioMarin Announces Planned Changes to Board of Directors Leadership Structure391
Appendix401
  Methodology401
  About GlobalData401
  Contact Us401
  Disclaimer401

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "BioMarin Pharmaceutical Inc. (BMRN) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. May 03, 2025. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/BioMarin-Pharmaceutical-Inc-BMRN-Medical-Equipment-Deals-and-Alliances-Profile-2148-21386>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). BioMarin Pharmaceutical Inc. (BMRN) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved May 03, 2025 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/BioMarin-Pharmaceutical-Inc-BMRN-Medical-Equipment-Deals-and-Alliances-Profile-2148-21386>
  
US$ 250.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research